[단독] 김남규 라데팡스 대표, 신규 PEF 설립 추진

Activist investor Kim Nam-kyoo's establishment of a new PEF signals a broader shift in Korean enterprises toward governance-focused private equity intervention. His board appointment at Hanmi Pharmaceutical, leveraging M&A and crisis management expertise, positions him to drive operational improvements and shareholder value creation. This reflects growing market recognition of governance restructuring as a key lever for addressing management challenges in underperforming Korean companies.